vs

Side-by-side financial comparison of Amneal Pharmaceuticals, Inc. (AMRX) and Evergy (EVRG). Click either name above to swap in a different company.

Evergy is the larger business by last-quarter revenue ($1.3B vs $722.5M, roughly 1.8× Amneal Pharmaceuticals, Inc.). Amneal Pharmaceuticals, Inc. runs the higher net margin — 10.8% vs 6.5%, a 4.3% gap on every dollar of revenue. On growth, Evergy posted the faster year-over-year revenue change (5.3% vs 3.9%). Over the past eight quarters, Amneal Pharmaceuticals, Inc.'s revenue compounded faster (1.5% CAGR vs 0.4%).

Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.

Evergy, Inc. is an American investor-owned utility (IOU) with publicly traded stock with headquarters in Topeka, Kansas, and in Kansas City, Missouri. The company was formed from a merger of Westar Energy of Topeka and Great Plains Energy of Kansas City, parent company of Kansas City Power & Light. Evergy is the largest electric company in Kansas, serving more than 1.7 million residential, commercial and industrial customers in Kansas and Missouri.

AMRX vs EVRG — Head-to-Head

Bigger by revenue
EVRG
EVRG
1.8× larger
EVRG
$1.3B
$722.5M
AMRX
Growing faster (revenue YoY)
EVRG
EVRG
+1.4% gap
EVRG
5.3%
3.9%
AMRX
Higher net margin
AMRX
AMRX
4.3% more per $
AMRX
10.8%
6.5%
EVRG
Faster 2-yr revenue CAGR
AMRX
AMRX
Annualised
AMRX
1.5%
0.4%
EVRG

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRX
AMRX
EVRG
EVRG
Revenue
$722.5M
$1.3B
Net Profit
$78.0M
$84.3M
Gross Margin
44.3%
Operating Margin
19.6%
18.5%
Net Margin
10.8%
6.5%
Revenue YoY
3.9%
5.3%
Net Profit YoY
410.5%
7.8%
EPS (diluted)
$0.19
$0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRX
AMRX
EVRG
EVRG
Q1 26
$722.5M
Q4 25
$814.3M
$1.3B
Q3 25
$784.5M
$1.8B
Q2 25
$724.5M
$1.4B
Q1 25
$695.4M
$1.3B
Q4 24
$730.5M
$1.2B
Q3 24
$702.5M
$1.8B
Q2 24
$701.8M
$1.4B
Net Profit
AMRX
AMRX
EVRG
EVRG
Q1 26
$78.0M
Q4 25
$35.1M
$84.3M
Q3 25
$2.4M
$475.0M
Q2 25
$22.4M
$171.3M
Q1 25
$12.2M
$125.0M
Q4 24
$-31.1M
$78.2M
Q3 24
$-156.0K
$465.6M
Q2 24
$6.0M
$207.0M
Gross Margin
AMRX
AMRX
EVRG
EVRG
Q1 26
44.3%
Q4 25
36.5%
Q3 25
34.9%
Q2 25
39.5%
Q1 25
36.8%
Q4 24
36.0%
Q3 24
38.4%
Q2 24
35.6%
Operating Margin
AMRX
AMRX
EVRG
EVRG
Q1 26
19.6%
Q4 25
13.8%
18.5%
Q3 25
9.0%
37.3%
Q2 25
15.4%
25.4%
Q1 25
14.4%
22.5%
Q4 24
10.4%
18.1%
Q3 24
12.6%
35.1%
Q2 24
13.6%
25.4%
Net Margin
AMRX
AMRX
EVRG
EVRG
Q1 26
10.8%
Q4 25
4.3%
6.5%
Q3 25
0.3%
26.9%
Q2 25
3.1%
12.6%
Q1 25
1.8%
9.7%
Q4 24
-4.3%
6.4%
Q3 24
-0.0%
26.0%
Q2 24
0.9%
14.7%
EPS (diluted)
AMRX
AMRX
EVRG
EVRG
Q1 26
$0.19
Q4 25
$0.10
$0.35
Q3 25
$0.01
$2.03
Q2 25
$0.07
$0.74
Q1 25
$0.04
$0.54
Q4 24
$-0.10
$0.34
Q3 24
$0.00
$2.02
Q2 24
$0.02
$0.90

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRX
AMRX
EVRG
EVRG
Cash + ST InvestmentsLiquidity on hand
$197.7M
$19.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$10.2B
Total Assets
$3.5B
$33.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRX
AMRX
EVRG
EVRG
Q1 26
$197.7M
Q4 25
$282.0M
$19.8M
Q3 25
$201.2M
$27.5M
Q2 25
$71.5M
$27.8M
Q1 25
$59.2M
$35.3M
Q4 24
$110.6M
$22.0M
Q3 24
$74.0M
$34.6M
Q2 24
$43.8M
$26.1M
Total Debt
AMRX
AMRX
EVRG
EVRG
Q1 26
Q4 25
$2.6B
Q3 25
$2.6B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.4B
Q3 24
$2.4B
Q2 24
$2.4B
Stockholders' Equity
AMRX
AMRX
EVRG
EVRG
Q1 26
Q4 25
$-70.8M
$10.2B
Q3 25
$-109.5M
$10.3B
Q2 25
$-112.1M
$10.0B
Q1 25
$-131.7M
$9.9B
Q4 24
$-109.3M
$10.0B
Q3 24
$-93.4M
$10.0B
Q2 24
$-57.5M
$9.7B
Total Assets
AMRX
AMRX
EVRG
EVRG
Q1 26
$3.5B
Q4 25
$3.7B
$33.9B
Q3 25
$3.6B
$33.4B
Q2 25
$3.4B
$32.9B
Q1 25
$3.4B
$32.5B
Q4 24
$3.5B
$32.3B
Q3 24
$3.5B
$32.1B
Q2 24
$3.5B
$31.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRX
AMRX
EVRG
EVRG
Operating Cash FlowLast quarter
$334.0M
Free Cash FlowOCF − Capex
$-530.5M
FCF MarginFCF / Revenue
-41.1%
Capex IntensityCapex / Revenue
66.9%
Cash ConversionOCF / Net Profit
3.96×
TTM Free Cash FlowTrailing 4 quarters
$-751.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRX
AMRX
EVRG
EVRG
Q1 26
Q4 25
$130.3M
$334.0M
Q3 25
$118.5M
$937.7M
Q2 25
$83.8M
$323.9M
Q1 25
$7.4M
$449.6M
Q4 24
$118.1M
$395.6M
Q3 24
$141.8M
$953.3M
Q2 24
$39.7M
$317.5M
Free Cash Flow
AMRX
AMRX
EVRG
EVRG
Q1 26
Q4 25
$108.5M
$-530.5M
Q3 25
$106.2M
$225.4M
Q2 25
$61.0M
$-303.4M
Q1 25
$-5.8M
$-143.2M
Q4 24
$102.9M
$-118.6M
Q3 24
$124.8M
$427.0M
Q2 24
$29.0M
$-360.0M
FCF Margin
AMRX
AMRX
EVRG
EVRG
Q1 26
Q4 25
13.3%
-41.1%
Q3 25
13.5%
12.8%
Q2 25
8.4%
-22.4%
Q1 25
-0.8%
-11.1%
Q4 24
14.1%
-9.7%
Q3 24
17.8%
23.9%
Q2 24
4.1%
-25.6%
Capex Intensity
AMRX
AMRX
EVRG
EVRG
Q1 26
Q4 25
2.7%
66.9%
Q3 25
1.6%
40.4%
Q2 25
3.2%
46.3%
Q1 25
1.9%
45.8%
Q4 24
2.1%
41.9%
Q3 24
2.4%
29.4%
Q2 24
1.5%
48.1%
Cash Conversion
AMRX
AMRX
EVRG
EVRG
Q1 26
Q4 25
3.72×
3.96×
Q3 25
50.00×
1.97×
Q2 25
3.74×
1.89×
Q1 25
0.61×
3.60×
Q4 24
5.06×
Q3 24
2.05×
Q2 24
6.62×
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRX
AMRX

Segment breakdown not available.

EVRG
EVRG

Electric Utility Customer Class Residential$462.9M36%
Electric Utility Customer Class Commercial$447.6M35%
Electric Utility Customer Class Industrial$164.1M13%
Electric Utility Customer Class Transmission$129.4M10%
Electric Utility Customer Class Wholesale$69.7M5%
Electric Utility Customer Class Other Retail$12.2M1%
Electric Utility Customer Class Industrial Steam$5.7M0%

Related Comparisons